Campbell, Ca., February 14, 2006 - Testing for Type Specific Herpes Simplex
Hunter Laboratories, Inc. now offers HerpeSelect®, an FDA approved test that can detect type-specific antibodies to both Herpes Simplex Viruses (HSV) I and II.
The signs and symptoms associated between the two types of HSV vary greatly.
Patient consultation and prognosis of recurrent genital outbacks, viral shedding, antibody persistance and neonatal transmission between HSV-I and HSV-II diagnosis differ.
The Centers for Disease Control and Prevention (CDC) recommend physicians to perform type-specific glycoprotein testing for HSV-I and HSV-II.
Accourding to the CDC at least 45 million people over the age of 12 have had a HSV infection.
The HerpeSelect from Focus is manufactured using recombinant technology and provides unequaled specificity compared to other currently available FDA approved tests.
